These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1097512)

  • 41. Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants.
    Ferrone S; Ting A; Pellegrino MA; Terasaki PI; Reisfeld RA
    J Clin Invest; 1975 Feb; 55(2):388-94. PubMed ID: 1092715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenetic analysis of H-2 mutations. III. Genetic mapping and involvement in immune reactions of the H-2ka mutation.
    Klein J; Forman J; Hauptfeld V; Egorov IK
    J Immunol; 1975 Sep; 115(3):716-8. PubMed ID: 125301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogeneic analysis of H-2 mutations. II. Cellular immunity to the H-2DA mutation.
    Forman J; Klein J
    J Immunol; 1975 Sep; 115(3):711-5. PubMed ID: 125300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute destruction by humoral antibody of rat skin grafted to mice.
    Winn HJ; Baldamus CA; Jooste SV; Russell PS
    J Exp Med; 1973 Apr; 137(4):893-910. PubMed ID: 4120896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of skin grafts in the mouse. The combined used of specific and nonspecific immunosuppression.
    Koene RA; Gerlag PG; McKenzie IF; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Sep; 20(3):241-7. PubMed ID: 1099730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.
    Brondz BD; Egorov IK; Drizlikh GI
    J Exp Med; 1975 Jan; 141(1):11-26. PubMed ID: 46906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Extension of graft survival time by means of a modification of the treatment with autologous blood].
    Seifert J
    Fortschr Med; 1979 Sep; 97(36):1576-80. PubMed ID: 387558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Similar activities of IgG1 and IgG2 alloantibodies in enhancement of mouse skin grafts and in opsonization.
    Lems SP; Rijke-Schilder TP; Capel PJ; Koene RA
    Transplantation; 1984 Mar; 37(3):291-6. PubMed ID: 6701959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 50. Procedure for the isolation of mouse anti H-2 antibodies from complex alloantisera.
    De Waal RM; Koene RA
    J Immunol Methods; 1977; 14(3-4):225-9. PubMed ID: 402423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Induction of lymphocytotoxic antibodies through transplantation of preserved allogeneic skin in mice].
    Schimmack L; Kaden J; Hackensellner HA
    Z Exp Chir; 1977; 10(5):275-84. PubMed ID: 337699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antigenic sites implicated in tumour allograft enhancement].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1977; 128(1-2):19-20. PubMed ID: 322579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of complement factors in acute antibody-mediated rejection of mouse skin allografts.
    Berden JH; Capel PJ; Koene RA
    Eur J Immunol; 1978 Mar; 8(3):158-62. PubMed ID: 350593
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of antibodies in the rejection and enhancement of organ allografts.?7318.
    Carpenter CB; d'Apice AJ; Abbas AK
    Adv Immunol; 1976; 22():1-65. PubMed ID: 769500
    [No Abstract]   [Full Text] [Related]  

  • 55. Cell-mediated hyperacute rejection. I. Acute, accelerated, and hyperacute reactions.
    Emam M; Eichwald EJ
    Transplantation; 1981 Mar; 31(3):156-9. PubMed ID: 7015608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Passive enhancement and hyperacute rejection of renal allografts in the rat.
    Winearls CG; Fabre JW; Hart DN; Millard PR; Morris PJ
    Transplantation; 1980 Jun; 29(6):462-7. PubMed ID: 6996236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative immunogenicity and enhanceability of individual H-2K and H-2D specificities of the murine histocompatibility-2 complex.
    McKenzie IF; Snell GD
    J Exp Med; 1973 Jul; 138(1):259-77. PubMed ID: 4123828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of requirement for polymorphonuclear granulocytes in the acute antibody-mediated rejection of murine skin allografts.
    Bogman MJ; Cornelissen IM; Koene RA
    Transplantation; 1984 Apr; 37(4):402-5. PubMed ID: 6369672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex.
    Sachs DH; Cone JL
    J Exp Med; 1973 Dec; 138(6):1289-304. PubMed ID: 4128439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro model of hyperacute organ rejection by allotransplantation sera.
    Wartenberg J; Milgrom F
    Transplant Proc; 1979 Jun; 11(2):1407-8. PubMed ID: 382524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.